|
⚲
|
| Disruptive Technology Solutions Biotechnology II LLC | |
|---|---|
| Firm |
Disruptive Technology Advisers LLC
✚
|
| Fund # | 805-6694330691 |
| CIK # | |
| Sale | |
| Fund | Other Private Fund |
| Phone | |
| Address | |
| Source | [IAPD] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | DTA II LLC |
| Custodian | Morgan Stanley Smith Barney LLC, Carta Securities LLC |
| Auditor | Baker Tilly US LLP |
| Marketer | Tribeca Holdings Limited, Group Capital LLC |
| Broker | |
| Jurisdiction |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Kumin Phillip Ralph
✚
|
0.0 | |
|
Kunde Jeffrey R
✚
|
0.0 | |
|
Kunde Roberta
✚
|
0.0 | |
|
KUNE 2021 A Series of Cgf2021 LLC
✚
|
0.0 | |
|
Kunst Fund II LP
✚
|
0.0 | |
|
Kuohn Sandra D.
✚
|
0.0 | |
|
Kuramo Africa Opportunity Fund II, L.P.
✚
|
0.0 | |
|
Kuramo Africa Opportunity Fund II Vehicle, L.P.
✚
|
0.0 | |
|
Kuramo Africa Opportunity Master Co-Investment Vehicle II, L
✚
|
0.0 | |
|
Ripple Macro Fund L.P.
✚
|
0.0 |